Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.

Spinelli, Orietta

Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. [electronic resource] - Haematologica May 2007 - 612-8 p. digital

Publication Type: Journal Article

1592-8721

10.3324/haematol.10965 doi


Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Basic Helix-Loop-Helix Transcription Factors--genetics
Benzamides
Biomarkers, Tumor--blood
Clinical Trials as Topic--statistics & numerical data
Cohort Studies
Combined Modality Therapy
Female
Fusion Proteins, bcr-abl--blood
Gene Deletion
Gene Rearrangement, B-Lymphocyte
Gene Rearrangement, T-Lymphocyte
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Kaplan-Meier Estimate
Kinetics
Leukemia-Lymphoma, Adult T-Cell--blood
Male
Middle Aged
Multicenter Studies as Topic
Myeloid-Lymphoid Leukemia Protein--blood
Neoplasm, Residual
Oncogene Proteins, Fusion--blood
Piperazines--administration & dosage
Polymerase Chain Reaction
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood
Proto-Oncogene Proteins--genetics
Pyrimidines--administration & dosage
Remission Induction
Risk
Survival Analysis
Survival Rate
T-Cell Acute Lymphocytic Leukemia Protein 1
Translocation, Genetic
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome